These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 21773733

  • 21. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.
    Kulp SK, Chen CS, Wang DS, Chen CY, Chen CS.
    Clin Cancer Res; 2006 Sep 01; 12(17):5199-206. PubMed ID: 16951239
    [Abstract] [Full Text] [Related]

  • 22. Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo.
    Dasmahapatra G, Lembersky D, Son MP, Attkisson E, Dent P, Fisher RI, Friedberg JW, Grant S.
    Mol Cancer Ther; 2011 Sep 01; 10(9):1686-97. PubMed ID: 21750224
    [Abstract] [Full Text] [Related]

  • 23. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.
    Xargay-Torrent S, López-Guerra M, Saborit-Villarroya I, Rosich L, Campo E, Roué G, Colomer D.
    Clin Cancer Res; 2011 Jun 15; 17(12):3956-68. PubMed ID: 21652541
    [Abstract] [Full Text] [Related]

  • 24. Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway.
    Ling Y, Xu C, Luo L, Cao J, Feng J, Xue Y, Zhu Q, Ju C, Li F, Zhang Y, Zhang Y, Ling X.
    J Med Chem; 2015 Dec 10; 58(23):9214-27. PubMed ID: 26555243
    [Abstract] [Full Text] [Related]

  • 25. Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.
    Chao H, Wang L, Hao J, Ni J, Chang L, Graham PH, Kearsley JH, Li Y.
    Cancer Lett; 2013 Feb 01; 329(1):17-26. PubMed ID: 22995071
    [Abstract] [Full Text] [Related]

  • 26. Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma.
    He L, Torres-Lockhart K, Forster N, Ramakrishnan S, Greninger P, Garnett MJ, McDermott U, Rothenberg SM, Benes CH, Ellisen LW.
    Cancer Discov; 2013 Mar 01; 3(3):324-37. PubMed ID: 23274910
    [Abstract] [Full Text] [Related]

  • 27. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers.
    Thapa RK, Nguyen HT, Jeong JH, Shin BS, Ku SK, Choi HG, Yong CS, Kim JO.
    Nanomedicine; 2017 Apr 01; 13(3):885-896. PubMed ID: 27993720
    [Abstract] [Full Text] [Related]

  • 28. MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.
    Labisso WL, Wirth M, Stojanovic N, Stauber RH, Schnieke A, Schmid RM, Krämer OH, Saur D, Schneider G.
    Cell Cycle; 2012 Apr 15; 11(8):1593-602. PubMed ID: 22456335
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma.
    Lautz TB, Naiditch JA, Clark S, Chu F, Madonna MB.
    J Pediatr Surg; 2012 Jun 15; 47(6):1267-71. PubMed ID: 22703804
    [Abstract] [Full Text] [Related]

  • 30. Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production.
    Yoon GE, Jung JK, Lee YH, Jang BC, In Kim J.
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar 15; 393(3):491-500. PubMed ID: 31655853
    [Abstract] [Full Text] [Related]

  • 31. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells.
    Mandl-Weber S, Meinel FG, Jankowsky R, Oduncu F, Schmidmaier R, Baumann P.
    Br J Haematol; 2010 May 15; 149(4):518-28. PubMed ID: 20201941
    [Abstract] [Full Text] [Related]

  • 32. 3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity.
    Lee HY, Lee JF, Kumar S, Wu YW, HuangFu WC, Lai MJ, Li YH, Huang HL, Kuo FC, Hsiao CJ, Cheng CC, Yang CR, Liou JP.
    Eur J Med Chem; 2017 Jan 05; 125():1268-1278. PubMed ID: 27886544
    [Abstract] [Full Text] [Related]

  • 33. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
    Ikezoe T, Hisatake Y, Takeuchi T, Ohtsuki Y, Yang Y, Said JW, Taguchi H, Koeffler HP.
    Cancer Res; 2004 Oct 15; 64(20):7426-31. PubMed ID: 15492266
    [Abstract] [Full Text] [Related]

  • 34. Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim.
    Dai Y, Chen S, Wang L, Pei XY, Kramer LB, Dent P, Grant S.
    Br J Haematol; 2011 Apr 15; 153(2):222-35. PubMed ID: 21375523
    [Abstract] [Full Text] [Related]

  • 35. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
    Festuccia C, Gravina GL, D'Alessandro AM, Muzi P, Millimaggi D, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2009 Jun 15; 16(2):401-13. PubMed ID: 19153211
    [Abstract] [Full Text] [Related]

  • 36. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
    Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q, Ji M, Pienta K, Lawrence T, Xu L.
    Mol Cancer Ther; 2008 Jul 15; 7(7):2192-202. PubMed ID: 18645028
    [Abstract] [Full Text] [Related]

  • 37. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H, Li GX, Wang L, Watts J, Combs GF, Lü J.
    Clin Cancer Res; 2008 Feb 15; 14(4):1150-8. PubMed ID: 18281549
    [Abstract] [Full Text] [Related]

  • 38. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY, Lu L, Adams M, Meyer B, Bartlett JB, Dalgleish AG, Galustian C.
    Prostate; 2012 Jun 01; 72(8):856-67. PubMed ID: 21968939
    [Abstract] [Full Text] [Related]

  • 39. Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies.
    Qian X, LaRochelle WJ, Ara G, Wu F, Petersen KD, Thougaard A, Sehested M, Lichenstein HS, Jeffers M.
    Mol Cancer Ther; 2006 Aug 01; 5(8):2086-95. PubMed ID: 16928830
    [Abstract] [Full Text] [Related]

  • 40. Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells.
    Phillip CJ, Giardina CK, Bilir B, Cutler DJ, Lai YH, Kucuk O, Moreno CS.
    BMC Cancer; 2012 Apr 11; 12():145. PubMed ID: 22494660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.